News
Short-course SBRT: Standard of care in prostate cancer?
Stereotactic body radiation therapy delivered in five fractions provided similar 5-year disease control as conventional, higher-dose external-beam...
News
Salvage option to replace transplant in r/r Hodgkin lymphoma?
“The findings suggest that children, adolescents, and young adults with low-risk relapsed classic Hodgkin lymphoma can be salvaged with low-...
News
Safely skip PET2 after brentuximab in Hodgkin lymphoma?
Recent data presented at SOHO 2023 suggested that adding brentuximab vedotin to chemotherapy for Hodgkin lymphoma improves outcomes, even without...
News
Is additional treatment needed, pretransplant, for r/r AML?
The issue of whether or not patients with r/r AML require additional treatment pretransplant was debated at SOHO 2023.
News
Urine test shows promise for diagnosing urothelial carcinoma
“The idea is that this could be used as kind of a first-pass screening tool for patients with hematuria that could potentially obviate the need...
News
Do some randomized controlled trials stack the deck?
“In the ethical design of clinical trials, patients make important sacrifices to participate, and in exchange, the academic and clinical...
News
Does private equity ensure survival of GI practices?
Private equity offers the allure of financial and administrative stability.
News
Geriatric care principles should apply to ICUs as well
Physical frailty, disabilities, and multimorbidities increase the risk for adverse outcomes among elderly patients with obstructive airways...
News
Multiprong strategy makes clinical trials less White
Only a small percentage of eligible patients participate in clinical trials in the first place, and very few come from racial and ethnic minority...
News
CBSM phone app eases anxiety, depression in cancer patients
Few patients with cancer have access to psycho-oncologic support.
News
T-DXd active in many solid tumors; ‘shift in thinking’
T-DXd is a potential new treatment option for patients with HER2-expressing solid tumors, experts say.
News
CAR T-cell benefit in lenalidomide-refractory myeloma
“Early CAR Ts demonstrating efficacy and safety and prior lines of treatment impact survival from CAR T in myeloma. Can this also be true for...
News
CMML: GM-CSF inhibitor lenzilumab shows early promise
The PREACH-M trial has yielded encouraging preliminary results in treating CMML, a rare, “insidious” leukemia that can transform into AML.
News
Less therapy may suit older patients with breast cancer
“Do we absolutely have to do a mastectomy for a patient who has a second episode of cancer in the same breast? The answer is no.”
News
Oral drug for brain tumor could change treatment landscape
Vorasidenib was associated with a significant delay in time to disease progression when compared with placebo, in a new study.